JD Supra: Mergers

MARCH 12, 2024

The year 2023 will be remembered as a challenging one for private equity (PE), with complexities to navigate on many fronts. Although overall transaction volume was significantly down, private equity funds still found. By: Akin Gump Strauss Hauer & Feld LLP

Private Equity 197

Private Equity Equities Debt Valuation 197

TechCrunch: M&A

DECEMBER 16, 2024

The company's spyware, dubbed Graphite, is capable of hacking phones and stealing private communications. 2024 TechCrunch. All rights reserved. For personal use only.

Private Equity 284

Private Equity Equities Mergers and Acquisitions Securities 284

JD Supra: Mergers

FEBRUARY 28, 2024

Traditionally, private equity firms were seen as benign investors from an antitrust perspective. This is changing. In the past 12 months, PE-funded acquisitions have faced progressively more rigorous scrutiny by antitrust authorities. By: Allen & Overy LLP

Private Equity 192

Private Equity Equities Funds Investors 192

JD Supra: Mergers

AUGUST 15, 2024

California’s Senate Appropriations Committee will hold a hearing on California’s private equity bill, AB 3129, on August 15, 2024. This proposed legislation would expand existing California Attorney General authority to include review and approval authority over most healthcare private equity transactions. By: BakerHostetler

Private Equity 183

Private Equity Equities Healthcare 183

JD Supra: Mergers

DECEMBER 13, 2024

Episode 12: Exploring Consolidation and Private Equity Investment in Physician Practice Management - In this episode of BRight Minds in Healthcare Delivery, host Eric Tower interviews Robert Aprill, a partner at Physician Growth Partners. Eric and Robert examine private equity (PE) investment in physician services, including various.

Private Equity 165

Private Equity Equities Investment Management 165

JD Supra: Mergers

AUGUST 19, 2024

California is looking to take the lead on regulating private equity deals in the health care space by introducing bill AB 3129, which requires private equity groups or hedge funds to receive the state attorney general’s approval before purchasing a health care entity. and may encourage other states to establish similar legislation.

Private Equity 188

Private Equity Equities Funds 188

JD Supra: Mergers

OCTOBER 17, 2023

USAP”) and its private equity sponsor, Welsh, Carson, Anderson & Stowe (“Welsh Carson”) alleging an anticompetitive scheme to consolidate anesthesiology practices in Texas through a series of systematic roll-ups; price setting arrangements; and a market allocation agreement to dominate the anesthesia market in Texas.

Private Equity 276

Private Equity Equities Acquisitions Trading 276

JD Supra: Mergers

JUNE 3, 2024

Private equity firms can breathe a sigh of relief after a federal judge dismissed claims that threatened to establish a precedent for holding private equity firms liable for certain actions by their portfolio companies. By: Troutman Pepper

Private Equity 177

Private Equity Equities Portfolio 177

JD Supra: Mergers

MARCH 8, 2024

Private equity is squarely in the cross hairs of regulators; the Department of Justice Antitrust Division, the Federal Trade Commission, and the U.S. Department of Health and Human Services recently announced the launch of a joint inquiry into private equity ownership in the health care field. By: Ballard Spahr LLP

Private Equity 192

Private Equity Equities Acquisitions Trading 192

JD Supra: Mergers

MAY 13, 2024

In corporate transactions of all kinds—mergers, acquisitions, and other business combinations—the purchaser company (Purchaser) must confront the question of how to treat the outstanding equity awards and the current equity incentive compensation plan of the target company in the transaction (Target). By: Morgan Lewis

Equities 159

Equities Corporation Mergers and Acquisitions Mergers 159

JD Supra: Mergers

JUNE 4, 2024

Private equity sponsors can exhale: A federal court recently stopped the Federal Trade Commission's (FTC) antitrust action that targeted private equity sponsor Welsh, Carson, Anderson & Stowe for the healthcare "roll-up" strategy of its anesthesia practice management portfolio company. The case, Federal Trade Commission v.

Private Equity 188

Private Equity Healthcare Equities Portfolio 188

JD Supra: Mergers

MARCH 12, 2024

Private equity acquisitions in healthcare will likely face increased scrutiny from multiple federal departments, as well as from state antitrust enforcement officials. By: Mayer Brown

Private Equity 183

Private Equity Healthcare Equities Acquisitions 183

JD Supra: Mergers

SEPTEMBER 9, 2024

By: Troutman Pepper

Private Equity 177

Private Equity Equities Mergers and Acquisitions M&A 177

JD Supra: Mergers

SEPTEMBER 23, 2024

On August 31, the last day of its 2024 Legislative Session, the California Legislature approved Assembly Bill 3129 (Wood), which provides for notification to and review by the Attorney General of health care transactions involving private equity groups and hedge funds. Governor Newsom is expected to sign the legislation in September.

Private Equity 171

Private Equity Equities Healthcare Funds 171

JD Supra: Mergers

MARCH 8, 2024

On March 5, the Federal Trade Commission (FTC) hosted a public workshop titled “Private Capital, Public Impact: An FTC Workshop on Private Equity in Health Care.” The event is part of the agency’s effort to publicize and encourage enforcement targeting private equity investments in health care.

Private Equity 188

Private Equity Equities Capital Trading 188

JD Supra: Mergers

AUGUST 2, 2024

Venable's Private Equity Investment in Healthcare webinar series explores the unique issues and timely developments that shape deals within the industry. Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. By: Venable LLP

Private Equity 171

Private Equity Healthcare Equities Investment 171

JD Supra: Mergers

APRIL 1, 2024

The California legislature is considering a bill that could severely impact the ability for private equity companies and hedge funds to operate in the California health care industry. By: Polsinelli

Private Equity 183

Private Equity Equities Funds Investment 183

JD Supra: Mergers

MAY 8, 2024

Congratulations to those who won a cannabis social equity license in the Maryland lottery! To take advantage of this exciting business endeavor, check out these suggested priority actions and read on for essential considerations around raising capital.

Equities 171

Equities Capital Business 171

JD Supra: Mergers

AUGUST 23, 2024

The term “rollover equity” is frequently used in discussions about the sale of middle market companies (which often is described as meaning companies with enterprise values from $10 million to $1 billion[1]), but frequently is not well understood by people selling middle market companies (particularly founder or family-owned companies).

Middle Market 165

Middle Market Equities M&A Sale 165

JD Supra: Mergers

MARCH 12, 2024

On March 5, the FTC convened a workshop with regulators, academics and stakeholders to discuss the impact of private equity in the healthcare market. The workshop reflects the FTC and DOJ Antitrust Division’s recent focus on private equity and serial roll-up transactions more broadly as targets for antitrust enforcement.

Private Equity 171

Private Equity Healthcare Equities Acquisitions 171

JD Supra: Mergers

SEPTEMBER 26, 2024

The California Legislature recently passed Assembly Bill 3129 (“AB 3129” or the “Bill”), which, if signed by California Governor Gavin Newsom, would increase oversight of healthcare entity transactions involving private equity investment. Governor Newsom has until September 30, 2024, to sign or veto the Bill. By: Arnall Golden Gregory LLP

Private Equity 177

Private Equity Healthcare Equities Investment 177

JD Supra: Mergers

SEPTEMBER 10, 2024

For the sixth consecutive year, Dechert is the contributing editor of the International Comparative Legal Guide - Private Equity.

Private Equity 152

Private Equity Equities Government IT 152

JD Supra: Mergers

AUGUST 5, 2024

The Massachusetts legislative session for 2024 has come to a close without the passage of a bill that would have targeted private equity in healthcare.

Private Equity 171

Private Equity Healthcare Equities Funds 171

JD Supra: Mergers

MAY 22, 2024

McGuireWoods recently held its 20th Annual Healthcare Private Equity and Finance Conference (HCPE Conference) in Chicago. The conference drew more than 1,000 professionals from private equity funds, senior and mezzanine lenders, and investment banks, as well as C-level executives, consultants and principals in the healthcare industry.

Private Equity 165

Private Equity Healthcare Finance Finance 165

JD Supra: Mergers

AUGUST 1, 2024

Over the last decade, private equity firms have acquired healthcare companies, hospitals, and clinics at an increasing rate. In fact, in those ten years, private equity firms have spent roughly $1 trillion on an estimated 8,000 healthcare deals. This trend is only expected to increase through 2024.

Private Equity 159

Private Equity Healthcare Equities Portfolio 159

JD Supra: Mergers

AUGUST 29, 2024

Driven by a growing wave of enforcer skepticism toward further healthcare consolidation, some state legislatures have begun to propose “mini-HSR” laws explicitly targeting healthcare transactions involving private equity firms or sponsors. By: Morgan Lewis

Private Equity 171

Private Equity Healthcare Equities 171

JD Supra: Mergers

MARCH 8, 2024

A recent government initiative announced on March 5, 2024 signals that more antitrust scrutiny for private equity firms and asset managers is on the horizon. By: Paul Hastings LLP

Private Equity 165

Private Equity Equities Healthcare Asset Management 165

JD Supra: Mergers

AUGUST 1, 2024

Private equity investment in health care has grown significantly over the past two decades, and the US government is starting to pay attention. The False Claims Act (FCA) appears to be the first avenue of enforcement, but private equity firms should be prepared for state. By: K&L Gates LLP

Private Equity 177

Private Equity Equities Medical Government 177

JD Supra: Mergers

MAY 17, 2024

a federal district court granted private equity firm Welsh, Carson, Anderson & Stowe's motion to dismiss it from the Federal Trade Commission's (FTC) lawsuit alleging an anticompetitive scheme to drive up the price of anesthesia services by orchestrating a decade-long "roll-up" strategy to consolidate anesthesiology practices in Texas.

Private Equity 177

Private Equity Equities Trading IT 177

JD Supra: Mergers

MAY 30, 2024

The Federal Trade Commission’s (FTC) push against private equity roll-ups has hit a snag. Judge Hoyt found that the FTC had not adequately alleged that Welsh Carson “is violating” or “is about to violate” antitrust laws, as required under.

Private Equity 188

Private Equity Equities Trading 188

JD Supra: Mergers

MARCH 8, 2024

WindRose Health Investors has announced its acquisition of CardioOne. CardioOne, founded in 2023 and based in Houston, is a management services partner and technology platform designed for independent cardiology practices. By: McGuireWoods LLP

Private Equity 268

Private Equity Healthcare Equities Investors 268

JD Supra: Mergers

MAY 21, 2024

What do private equity and growth capital investors look for when adding new companies to their portfolio, and what strategies do they apply to help those companies optimize capital? They covered the current private equity landscape, strategies for creating value, industry trends, various investment structures, and more.

Private Equity 171

Private Equity Equities Capital Mergers and Acquisitions 171

JD Supra: Mergers

AUGUST 1, 2024

At the end of last year, Holland & Knight predicted that "the current enforcement environment will continue into 2024 and will focus heavily on the healthcare industry, along with private equity transactions or 'roll-ups.' 15, 2023.)

Private Equity 171

Private Equity Healthcare Equities 171

JD Supra: Mergers

OCTOBER 15, 2024

According to EY’s Private Equity Pulse, Q2 2024 was the strongest quarter in two years, with 122 announced transactions at a valuation of $196 billion total enterprise value. This seems to be the case, as we see initial signs of an improving landscape after a stronger Q2. But the US PE market is. By: Woodruff Sawyer

Private Equity 177

Private Equity Equities Insurance Valuation 177

JD Supra: Mergers

JUNE 12, 2024

Episode 7: Exploring the Role of Operating Partners in Private Equity In this episode of BRight Minds in Healthcare Delivery, Donna Cooper joins host Eric Tower for a conversation about her career and how her prior experience has influenced her current role as an operating partner. Donna explains the role of an operating partner at….

Private Equity 165

Private Equity Equities Healthcare 165

JD Supra: Mergers

APRIL 22, 2024

A recently introduced California Assembly Bill (AB 3129), targeting private equity (PE) physician practice investments, is currently making its way through the legislative process.

Private Equity 177

Private Equity Equities Investment Acquisitions 177

JD Supra: Mergers

OCTOBER 1, 2024

Gavin Newsom vetoed a controversial bill that would have restricted private equity and hedge fund healthcare transactions in the state. On Saturday, September 28, California Gov. By: Fenwick & West LLP

Private Equity 165

Private Equity Healthcare Equities Funds 165